Detalles de la búsqueda
1.
Real clinical outcomes of nivolumab plus ipilimumab for renal cell carcinoma in patients over 75 years old.
Int J Clin Oncol
; 28(11): 1530-1537, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37552353
2.
[Advanced Adrenocortical Carcinoma with Vena Caval Tumor Thrombus Treated with Extended Surgery and Subsequent Chemotherapy].
Hinyokika Kiyo
; 65(10): 397-402, 2019 Oct.
Artículo
en Japonés
| MEDLINE | ID: mdl-31697884
3.
[Tuberous Sclerosis Complex Detected by Spontaneous Rupture of a Giant Renal Angiomyolipoma : A Case Report].
Hinyokika Kiyo
; 63(3): 111-114, 2017 Mar.
Artículo
en Japonés
| MEDLINE | ID: mdl-28331168
4.
Influence of genetic polymorphisms in vascular endothelial-related genes on the clinical outcome of axitinib in patients with metastatic renal cell carcinoma.
Cancer Biol Ther
; 25(1): 2312602, 2024 12 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38327067
5.
Complete remission of brain metastases in renal cell carcinoma treated with axitinib after failure with nivolumab and ipilimumab treatment.
IJU Case Rep
; 5(6): 517-520, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36341192
6.
Short-term outcomes of risk-adapted upfront docetaxel administration in patients with metastatic hormone-sensitive prostate cancer: a multicenter prospective study in Japan.
Med Oncol
; 38(4): 37, 2021 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33713196
7.
Contribution of UGT1A1 genetic polymorphisms related to axitinib pharmacokinetics to safety and efficacy in patients with renal cell carcinoma.
Med Oncol
; 35(4): 51, 2018 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29524031
8.
Clinical implications of pharmacokinetics of sunitinib malate and N-desethyl-sunitinib plasma concentrations for treatment outcome in metastatic renal cell carcinoma patients.
Oncotarget
; 9(38): 25277-25284, 2018 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-29861870
Resultados
1 -
8
de 8
1
Próxima >
>>